The community is narrowly leaning bullish on Novartis at 53%, based on 177 forecasts. Forecasters are in moderate agreement.
Forecast right here — tap a card, set your odds, lock it in. You're scored on what actually happens, and sharper calls climb the leaderboard.
Tap a level to set your odds it finishes there or higher
Next 3 months· 6
Next 6 months· 3
Six months and beyond· 3